Pivenfrine

This classification denotes an adrenergic agent with the molecular formula C14H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RB4XQ0T71U, chemically known as propanoic acid, 2,2-dimethyl-, 3-(1-hydroxy-2-(methylamino)ethyl)phenyl ester but generally known as pivenfrine, which bears US NIH Compound Identifier 130545. European Medicines Agency schedules Pivenfrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09950MIG. The term PIVENFRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). PIVENFRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pivenfrine under HS 29225000 and SITC 51467. As of Q4 2014, PIVENFRINE remains the US FDA Preferred Term for this commodity. Pivenfrine bears US NLM identifiers UMLS ID C1882403 and NCI Concept Code C66442. SMILES: O(C(=O)C(C)(C)C)C1CC(C(O)CNC)CCC1.